End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
31.09
CNY
|
-2.51%
|
|
-4.34%
|
+2.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
17,314
|
19,271
|
44,307
|
39,111
|
27,782
|
28,338
|
-
|
Enterprise Value (EV)
1 |
17,314
|
19,271
|
44,307
|
39,111
|
27,782
|
28,338
|
28,338
|
P/E ratio
|
31.3
x
|
29.2
x
|
48.8
x
|
33.3
x
|
30.8
x
|
21.5
x
|
17.3
x
|
Yield
|
-
|
-
|
-
|
1.49%
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.68
x
|
-
|
-
|
4.31
x
|
3.54
x
|
2.56
x
|
2.2
x
|
EV / Revenue
|
3.68
x
|
-
|
-
|
4.31
x
|
3.54
x
|
2.56
x
|
2.2
x
|
EV / EBITDA
|
-
|
-
|
-
|
23.2
x
|
20
x
|
15.6
x
|
13.3
x
|
EV / FCF
|
-
|
-
|
-
|
-63,113,232
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-0%
|
-
|
-
|
-
|
Price to Book
|
2.91
x
|
-
|
-
|
4.77
x
|
3.26
x
|
2.94
x
|
2.61
x
|
Nbr of stocks (in thousands)
|
896,625
|
917,230
|
919,230
|
911,474
|
911,474
|
911,474
|
-
|
Reference price
2 |
19.31
|
21.01
|
48.20
|
42.91
|
30.48
|
31.09
|
31.09
|
Announcement Date
|
4/15/20
|
4/15/21
|
4/19/22
|
4/21/23
|
4/29/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
4,701
|
-
|
-
|
9,068
|
7,852
|
11,056
|
12,868
|
EBITDA
1 |
-
|
-
|
-
|
1,689
|
1,388
|
1,817
|
2,138
|
EBIT
1 |
511.8
|
-
|
-
|
1,279
|
922.4
|
1,435
|
1,808
|
Operating Margin
|
10.89%
|
-
|
-
|
14.1%
|
11.75%
|
12.98%
|
14.05%
|
Earnings before Tax (EBT)
1 |
607.1
|
-
|
-
|
1,335
|
969.5
|
1,492
|
1,860
|
Net income
1 |
525.1
|
647.8
|
891.5
|
1,165
|
899.8
|
1,318
|
1,642
|
Net margin
|
11.17%
|
-
|
-
|
12.85%
|
11.46%
|
11.92%
|
12.76%
|
EPS
2 |
0.6162
|
0.7186
|
0.9880
|
1.287
|
0.9902
|
1.445
|
1.800
|
Free Cash Flow
|
-
|
-
|
-
|
-619.7
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-6.83%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.6400
|
-
|
-
|
-
|
Announcement Date
|
4/15/20
|
4/15/21
|
4/19/22
|
4/21/23
|
4/29/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-620
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.94%
|
-
|
-
|
15.2%
|
10.8%
|
11.4%
|
14.2%
|
13.8%
|
ROA (Net income/ Total Assets)
|
6.07%
|
-
|
-
|
7.55%
|
-
|
-
|
-
|
-
|
Assets
1 |
8,649
|
-
|
-
|
15,425
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
6.640
|
-
|
-
|
9.000
|
9.360
|
10.20
|
11.70
|
-
|
Cash Flow per Share
2 |
0.9500
|
-
|
-
|
1.090
|
1.200
|
0.8900
|
1.840
|
-
|
Capex
1 |
252
|
-
|
-
|
1,614
|
1,007
|
541
|
246
|
252
|
Capex / Sales
|
5.36%
|
-
|
-
|
17.79%
|
12.82%
|
6.01%
|
2.13%
|
2.19%
|
Announcement Date
|
4/15/20
|
4/15/21
|
4/19/22
|
4/21/23
|
4/29/24
|
-
|
-
|
-
|
Last Close Price
31.09
CNY Average target price
37.12
CNY Spread / Average Target +19.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.00% | 4.01B | | +4.41% | 103B | | +1.20% | 68.41B | | +44.29% | 39.97B | | +15.99% | 38.97B | | +5.14% | 33.12B | | +5.29% | 19.41B | | +12.32% | 16.73B | | +8.31% | 15.34B | | +17.69% | 15.07B |
Other Commodity Chemicals
|